US OptionsDetailed Quotes
AMRX241220C10000
- 0.07
- 0.000.00%
15min DelayClose Nov 29 12:30 ET
0.00High0.00Low
0.07Open0.07Pre Close0 Volume4.83K Open Interest10.00Strike Price0.00Turnover66.47%IV21.77%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.1212Delta0.1615Gamma118.14Leverage Ratio-0.0067Theta0.0005Rho14.32Eff Leverage0.0038Vega
Amneal Pharmaceuticals Stock Discussion
Sign in to post a comment
This is a list in progress
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not...
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not...
39
13
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· 2 mins ago
Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
Amneal Resubmits Dhe Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, Its First Generic Injectable GLP-1 Agonist
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
$Amneal Pharmaceuticals (AMRX.US)$ Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...
5 MINUTES AGO, 6:00 AM EDT
VIA BUSINESSWIRE
Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera's portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists
Agreement provides Amneal w...
$Amneal Pharmaceuticals (AMRX.US)$ Reuters
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration
Amneal and Shilpa Announce U.S. FDA Approval of Boruzu™, the First Ready-to-Use Version of Bortezomib for Subcutaneous Administration
2
45
$Amneal Pharmaceuticals (AMRX.US)$ Reuters· just1
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials! expects launch in Q4
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials! expects launch in Q4
1
FDA Approves CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Parkinson's Disease: A New Horizon in Treatment.
Amneal Pharmaceuticals, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease (PD). This novel formulation promises to address some of the longstanding cha...
Amneal Pharmaceuticals, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease (PD). This novel formulation promises to address some of the longstanding cha...
$Amneal Pharmaceuticals (AMRX.US)$ But this will also be at the top of my list in PM as well as into MO🤫
1
4
3
2
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
No comment yet
105642463xu : $KULR Technology (KULR.US)$
Jaguar8 OP 105642463xu : Yup its on my watchlist
Rosscco : Thanks for the tip !
Adria87 : Thank You for the tip
baqklin : not a good play if 66% is moved to dark pool?
View more comments...